751 related articles for article (PubMed ID: 37561226)
21. Accessible and Adaptable Multiplexed Real-Time PCR Approaches to Identify SARS-CoV-2 Variants of Concern.
Yan T; Xu Y; Zheng R; Zeng X; Chen Z; Lin S; Xia Z; Liao Y; Zhang Y; Li Q
Microbiol Spectr; 2022 Oct; 10(5):e0322222. PubMed ID: 36106882
[TBL] [Abstract][Full Text] [Related]
22. Development of multiplex allele-specific RT-qPCR assays for differentiation of SARS-CoV-2 Omicron subvariants.
Li J; Cheng R; Bian Z; Niu J; Xia J; Mao G; Liu H; Wu C; Hao C
Appl Microbiol Biotechnol; 2024 Dec; 108(1):35. PubMed ID: 38183475
[TBL] [Abstract][Full Text] [Related]
23. Detection of SARS-CoV-2 in Saliva and Nasopharyngeal Swabs According to Viral Variants.
Salmona M; Chaix ML; Feghoul L; Mahjoub N; Maylin S; Schnepf N; Jacquier H; Walle EM; Helary M; Mellon G; Osinski N; Zebiche W; Achili Y; Amarsy R; Mahé V; Le Goff J; Delaugerre C
Microbiol Spectr; 2022 Dec; 10(6):e0213322. PubMed ID: 36346252
[TBL] [Abstract][Full Text] [Related]
24. Digital PCR Discriminates between SARS-CoV-2 Omicron Variants and Immune Escape Mutations.
Holland SC; Holland LA; Smith MF; Lee MB; Hu JC; Lim ES
Microbiol Spectr; 2023 Aug; 11(4):e0525822. PubMed ID: 37306573
[TBL] [Abstract][Full Text] [Related]
25. Virus variant-specific clinical performance of SARS coronavirus two rapid antigen tests in point-of-care use, from November 2020 to January 2022.
Wagenhäuser I; Knies K; Hofmann D; Rauschenberger V; Eisenmann M; Reusch J; Gabel A; Flemming S; Andres O; Petri N; Topp MS; Papsdorf M; McDonogh M; Verma-Führing R; Scherzad A; Zeller D; Böhm H; Gesierich A; Seitz AK; Kiderlen M; Gawlik M; Taurines R; Wurmb T; Ernestus RI; Forster J; Weismann D; Weißbrich B; Dölken L; Liese J; Kaderali L; Kurzai O; Vogel U; Krone M
Clin Microbiol Infect; 2023 Feb; 29(2):225-232. PubMed ID: 36028089
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of antiviral drugs against newly emerged SARS-CoV-2 Omicron subvariants.
Cho J; Shin Y; Yang JS; Kim JW; Kim KC; Lee JY
Antiviral Res; 2023 Jun; 214():105609. PubMed ID: 37086978
[TBL] [Abstract][Full Text] [Related]
27. Epidemiological Insights into the Omicron Outbreak via MeltArray-Assisted Real-Time Tracking of SARS-CoV-2 Variants.
Yan T; Zheng R; Li Y; Sun S; Zeng X; Yue Z; Liao Y; Hu Q; Xu Y; Li Q
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140638
[TBL] [Abstract][Full Text] [Related]
28. Analysis of seven SARS-CoV-2 rapid antigen tests in detecting omicron (B.1.1.529) versus delta (B.1.617.2) using cell culture supernatants and clinical specimens.
Jungnick S; Hobmaier B; Paravinja N; Mautner L; Hoyos M; Konrad R; Haase M; Baiker A; Eberle U; Bichler M; Treis B; Okeyo M; Streibl B; Wimmer C; Hepner S; Sprenger A; Berger C; Weise L; Dangel A; Ippisch S; Jonas W; Wildner M; Liebl B; Ackermann N; Sing A; Fingerle V;
Infection; 2023 Feb; 51(1):239-245. PubMed ID: 35596057
[TBL] [Abstract][Full Text] [Related]
29. OraSure InteliSwab
Weishampel ZA; Young J; Fischl M; Fischer RJ; Donkor IO; Riopelle JC; Schulz JE; Port JR; Saturday TA; van Doremalen N; Berry JD; Munster VJ; Yinda CK
Viruses; 2022 Mar; 14(3):. PubMed ID: 35336950
[TBL] [Abstract][Full Text] [Related]
30. Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity.
Muik A; Lui BG; Quandt J; Diao H; Fu Y; Bacher M; Gordon J; Toker A; Grosser J; Ozhelvaci O; Grikscheit K; Hoehl S; Kohmer N; Lustig Y; Regev-Yochay G; Ciesek S; Beguir K; Poran A; Vogler I; Türeci Ö; Sahin U
Cell Rep; 2023 Aug; 42(8):112888. PubMed ID: 37527039
[TBL] [Abstract][Full Text] [Related]
31. Accelerating pandemic response with the emergency Omicron RT-PCR test: A comprehensive solution for COVID-19 diagnosis and tracking.
Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Chen CS; Tang SH; Perng CL; Chang FY; Wang CH; Hung YJ; Shang HS
J Med Virol; 2023 Jul; 95(7):e28914. PubMed ID: 37394776
[TBL] [Abstract][Full Text] [Related]
32. Analytical performance of the rapid qualitative antigen kit for the detection of SARS-CoV-2 during widespread circulation of the Omicron variant.
Suzuki H; Akashi Y; Kato D; Takeuchi Y; Kiyasu Y; Terada N; Kurihara Y; Kuwahara M; Muramatsu S; Ueda A; Notake S; Nakamura K
J Infect Chemother; 2023 Mar; 29(3):257-262. PubMed ID: 36417995
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Four Point of Care (POC) Antigen Assays for the Detection of the SARS-CoV-2 Variant Omicron.
Hardick J; Gallagher N; Sachithanandham J; Fall A; Siddiqui Z; Pekosz A; Manabe YC; Mostafa HH
Microbiol Spectr; 2022 Jun; 10(3):e0102522. PubMed ID: 35616382
[TBL] [Abstract][Full Text] [Related]
34. Tracking SARS-CoV-2 variants during the 2023 flu season and beyond in Lebanon.
Kodsi IA; Rayes DE; Koweyes J; Khoury CA; Rahy K; Thoumi S; Chamoun M; Haddad H; Mokhbat J; Tokajian S
Virus Res; 2024 Jan; 339():199289. PubMed ID: 38036064
[TBL] [Abstract][Full Text] [Related]
35. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study.
Tan CY; Chiew CJ; Pang D; Lee VJ; Ong B; Lye DC; Tan KB
Lancet Infect Dis; 2023 Jul; 23(7):799-805. PubMed ID: 36924786
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 rapid antigen test sensitivity and viral load in newly symptomatic hospital employees in Berlin, Germany, December, 2020 to February, 2022: an observational study.
Meiners L; Horn J; Jones TC; Mühlemann B; Schmidt ML; Walper F; Menzel P; Schwarzer R; Rose R; Krumbholz A; Corman VM; Seybold J; Drosten C
Lancet Microbe; 2024 Jun; 5(6):e538-e546. PubMed ID: 38759669
[TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2 Omicron XBB subvariants exhibit enhanced fusogenicity and substantial immune evasion in elderly population, but high sensitivity to pan-coronavirus fusion inhibitors.
Xia S; Jiao F; Wang L; Yu X; Lu T; Fu Y; Huang Z; Li X; Huang J; Wang Q; Man Q; Xiong L; Jiang S; Lu L
J Med Virol; 2023 Mar; 95(3):e28641. PubMed ID: 36890632
[TBL] [Abstract][Full Text] [Related]
38. Rapid SARS-CoV-2 Variants Enzymatic Detection (SAVED) by CRISPR-Cas12a.
Yang J; Barua N; Rahman MN; Li C; Lo N; Yeong KY; Tsang TF; Yang X; Cheung YY; Tsang AKL; Chan RCW; Leung EC; Chan PKS; Ip M
Microbiol Spectr; 2022 Dec; 10(6):e0326022. PubMed ID: 36342324
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic performance of rapid antigen tests (RAT) for COVID-19 and factors associated with RAT-negative results among RT-PCR-positive individuals during Omicron BA.2, BA.5 and XBB.1 predominance.
Tan CY; Zeng K; Cui L; Lin RTP; Chen M
BMC Infect Dis; 2024 May; 24(1):504. PubMed ID: 38769524
[TBL] [Abstract][Full Text] [Related]
40. Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected With Omicron Subvariants and the XBB Recombinant Variant.
Karyakarte RP; Das R; Dudhate S; Agarasen J; Pillai P; Chandankhede PM; Labhshetwar RS; Gadiyal Y; Rajmane MV; Kulkarni PP; Nizarudeen S; Joshi S; Potdar V; Karmodiya K
Cureus; 2023 Feb; 15(2):e35261. PubMed ID: 36968876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
